Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study

Proton pump inhibitor (PPI) twice daily dosing is a standard therapy for gastroesophageal reflux disease (GERD) in systemic sclerosis (SSc) but there is no data on its response rate or the predictors of PPI-partial response GERD. Aims were to determine the prevalence of PPI-partial response GERD in...

Descripción completa

Detalles Bibliográficos
Autores principales: Foocharoen, Chingching, Chunlertrith, Kitti, Mairiang, Pisaln, Mahakkanukrauh, Ajanee, Suwannaroj, Siraphop, Namvijit, Suwassa, Wantha, Orathai, Nanagara, Ratanavadee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972652/
https://www.ncbi.nlm.nih.gov/pubmed/31964957
http://dx.doi.org/10.1038/s41598-020-57636-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972652/
https://www.ncbi.nlm.nih.gov/pubmed/31964957
http://dx.doi.org/10.1038/s41598-020-57636-0

Ejemplares similares